Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Candida glabrata infections are increasing worldwide and exhibit greater rates of antifungal resistance than those with other species. DNA mismatch repair (MMR) gene deletions, such as msh2Δ , in C. glabrata resulting in a mutator phenotype have recently been reported to facilitate rapid acquisition of antifungal resistance. This study determined the antifungal susceptibility profiles of 210 C. glabrata isolates in 10 hospitals in India and investigated the impact of novel MSH2 polymorphisms on mutation potential. No echinocandin- or azole-resistant strains and no mutations in FKS hot spot regions were detected among the C. glabrata isolates, supporting our in vitro susceptibility testing results. CLSI antifungal susceptibility data showed that the MICs of anidulafungin (geometric mean [GM], 0.12 μg/ml) and micafungin (GM, 0.01 μg/ml) were lower and below the susceptibility breakpoint compared to that of caspofungin (CAS) (GM, 1.31 μg/ml). Interestingly, 69% of the C. glabrata strains sequenced contained six nonsynonymous mutations in MSH2 , i.e., V239L and the novel mutations E459K, R847C, Q386K, T772S, and V239/D946E. Functional analysis of MSH2 mutations revealed that 49% of the tested strains (40/81) contained a partial loss-of-function MSH2 mutation. The novel MSH2 substitution Q386K produced higher frequencies of CAS-resistant colonies upon expression in the msh2Δ mutant. However, expression of two other novel MSH2 alleles, i.e., E459K or R847C, did not confer selection of resistant colonies, confirming that not all mutations in the MSH2 MMR pathway affect its function or generate a phenotype of resistance to antifungal drugs. The lack of drug resistance prevented any correlations from being drawn with respect to MSH2 genotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“however, more recent work did not find a correlation between MSH2 mutations and antifungal resistance in vitro or in vivo69,70.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [70]
In the citing paper
“Consistent with this, MSH2 non-synonymous polymorphisms can be locally common, irrespective of the susceptibility of the isolates, as found for 69% (57/83) of susceptible clinical isolates in India [136].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [136]
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 7×
“R847Ca (6) Blood (4) 4 1 3 1 3 Respiratory tract (1) 1 1 1 Skin scraping (1) 1 1 1”
BackgroundInfluentialAlexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · cited 1×
“Several clinical studies have shown that the presence of an FKS mutation is the most important independent risk factor in predicting echinocandin therapeutic responses among patients with IC (3, 5).”
BackgroundSelf-citationChowdhary, A., Prakash, A., Sharma, C., Kordalewska, M., Kumar, A., Sarma, S., Tarai, B., Singh, A., Upadhyaya, G., Upadhyay, S., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx480 · Cited by 577
Self-citationIncidence, characteristics and outcome of ICU-acquired candidemia in India
Chakrabarti, A., Sood, P., Rudramurthy, S. M., Chen, S., Kaur, H., Capoor, M., Chhina, D., Rao, R., Eshwara, V. K., Xess, I., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-014-3603-2 · Cited by 454
Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377
Epidemiology of candidemia in Latin America: a laboratory-based survey
Nucci, M., Queiroz-Telles, F., Alvarado-Matute, T., Tiraboschi, I. N., Cortes, J., Zurita, J., Guzman-Blanco, M., Santolaya, M. E., Thompson, L., Sifuentes-Osornio, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059373 · Cited by 374
Healey, K. R., Zhao, Y., Perez, W. B., Lockhart, S. R., Sobel, J. D., Farmakiotis, D., Kontoyiannis, D. P., Sanglard, D., Taj-Aldeen, S. J., Alexander, B. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms11128 · Cited by 276 · cited 10×
“glabrata strains and is associated with a partial mutator phenotype (7).”
BackgroundMethodSelf-citationPham, C. D., Iqbal, N., Bolden, C. B., Kuykendall, R. J., Harrison, L. H., Farley, M. M., Schaffner, W., Beldavs, Z. G., Chiller, T. M., Park, B. J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03255-14 · Cited by 231
Bassetti, M., Merelli, M., Righi, E., Diaz-Martin, A., Rosello, E. M., Luzzati, R., Parra, A., Trecarichi, E. M., Sanguinetti, M., Posteraro, B., et al. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01998-13 · Cited by 228
Espinel-Ingroff, A., Arendrup, M. C., Pfaller, M. A., Bonfietti, L. X., Bustamante, B., Canton, E., Chryssanthou, E., Cuenca-Estrella, M., Dannaoui, E., Fothergill, A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01519-13 · Cited by 216 · cited 10×
“However, as expected, none of the isolates tested for MSH2 gene mutations had high MICs of AFG and MFG.”
BackgroundInfluential
Research works printed but not linked: 2
- Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved Standard, 3rd ed. CLSI document M27-A3. CLSI, Wayne, PA.
- Clinical and Laboratory Standards Institute. 2012. Reference method for broth dilution antifungal susceptibility testing of yeasts: fourth informational supplement M27-S4. CLSI, Wayne, PA.
Cited by
Tackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179
Drug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642
Emergence of a novel mobile colistin resistance gene, mcr-8 , in NDM-producing Klebsiella pneumoniae
Wang, X., Wang, Y., Zhou, Y., Li, J., Yin, W., Wang, S., Zhang, S., Shen, J., Shen, Z., & Wang, Y. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0124-z · Cited by 460
Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens
Ksiezopolska, E., & Gabaldón, T. (2018) · Genes · doi:10.3390/genes9090461 · Cited by 230
“Consistent with this, MSH2 non-synonymous polymorphisms can be locally common, irrespective of the susceptibility of the isolates, as found for 69% (57/83) of susceptible clinical isolates in India [136].”
BackgroundFungal resistance to echinocandins and the MDR phenomenon in Candida glabrata
Healey, K., & Perlin, D. S. (2018) · doi:10.20944/preprints201808.0306.v1 · Cited by 194
Self-citationFungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
Healey, K. R., & Perlin, D. S. (2018) · Journal of Fungi · doi:10.3390/jof4030105 · Cited by 194
Self-citationThe Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens
Arastehfar, A., Lass-Flörl, C., Garcia-Rubio, R., Daneshnia, F., Ilkit, M., Boekhout, T., Gabaldon, T., & Perlin, D. S. (2020) · Journal of Fungi · doi:10.3390/jof6030138 · Cited by 145
Self-citationResistance to Antifungal Drugs
Ben‐Ami, R., & Kontoyiannis, D. P. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.003 · Cited by 122
Billmyre, R. B., Applen Clancey, S., Li, L. X., Doering, T. L., & Heitman, J. (2020) · Nature Communications · doi:10.1038/s41467-019-13890-z · Cited by 102
Megri, Y., Arastehfar, A., Boekhout, T., Daneshnia, F., Hörtnagl, C., Sartori, B., Hafez, A., Pan, W., Lass-Flörl, C., & Hamrioui, B. (2020) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-020-00710-z · Cited by 65
Arastehfar, A. A., Daneshnia, F., Najafzadeh, M. J., Hagen, F., Mahmoudi, S., Salehi, M., Zarrinfar, H., Namvar, Z., Zareshahrabadi, Z., Khodavaisy, S., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00206 · Cited by 76
What’s new on emerging resistant Candida species
Cortegiani, A., Misseri, G., & Chowdhary, A. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5363-x · Cited by 68
Self-citationAdvances in understanding the evolution of fungal genome architecture
Priest, S. J., Yadav, V., & Heitman, J. (2020) · F1000Research · doi:10.12688/f1000research.25424.1 · Cited by 68
Beardsley, J., Kim, H. Y., Dao, A., Kidd, S. E., Alastruey‐Izquierdo, A., Sorrell, T. C., Tacconelli, E., Chakrabarti, A., Harrison, T. S., Bongomin, F., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae041 · Cited by 61
Arastehfar, A., Daneshnia, F., Zomorodian, K., Najafzadeh, M. J., Khodavaisy, S., Zarrinfar, H., Hagen, F., Zare Shahrabadi, Z., Lackner, M., Mirhendi, H., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02503-18 · Cited by 54
Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008–2018
Won, E. J., Choi, M. J., Kim, M., Yong, D., Lee, W. G., Uh, Y., Kim, T. S., Byeon, S. A., Lee, S. Y., Kim, S. H., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2703.203482 · Cited by 59
Zhang, H., Wei, W., Huang, M., Umar, Z., & Feng, Y. (2019) · Advanced Science · doi:10.1002/advs.201900038 · Cited by 57
Byun, S. A., Won, E. J., Kim, M.-N., Lee, W. G., Lee, K., Lee, H. S., Uh, Y., Healey, K. R., Perlin, D. S., Choi, M. J., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01523 · Cited by 51
Self-citationKaur, H., Singh, S., Rudramurthy, S. M., Ghosh, A. K., Jayashree, M., Yaddanapudi, L. N., Ray, P., & Chakrabarti, A. (2020) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_20_112 · Cited by 50
Arastehfar, A., Daneshnia, F., Salehi, M., Yaşar, M., Hoşbul, T., Ilkit, M., Pan, W., Hagen, F., Arslan, N., Türk‐Dağı, H., et al. (2020) · Mycoses · doi:10.1111/myc.13104 · Cited by 42
Self-citationRivero-Menéndez, O., Navarro-Rodríguez, P., Bernal‐Martínez, L., Martin-Cano, G., Lopez-Perez, L., Sánchez‐Romero, I., Pérez‐Ayala, A., Capilla, J., Zaragoza, Ó., & Alastruey‐Izquierdo, A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01585 · Cited by 47
Emergence of resistant Candida glabrata in Germany
Aldejohann, A. M., Herz, M., Martin, R., Walther, G., & Kurzai, O. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab122 · Cited by 41
Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan
Khalifa, H. O., Arai, T., Majima, H., Watanabe, A., & Kamei, K. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00783-20 · Cited by 42
dos Reis, T. F., Silva, L. P., de Castro, P. A., do Carmo, R. A., Marini, M. M., da Silveira, J. F., Ferreira, B. H., Rodrigues, F. J. S., Lind, A., Rokas, A., et al. (2019) · mSphere · doi:10.1128/msphere.00416-19 · Cited by 42
Arastehfar, A., Hilmioğlu-Polat, S., Daneshnia, F., Hafez, A., Salehi, M., Polat, F., Yaşar, M., Arslan, N., Hoşbul, T., Ünal, N., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.587278 · Cited by 40
Self-citationMutators Enhance Adaptive Micro-Evolution in Pathogenic Microbes
Boyce, K. J. (2022) · Microorganisms · doi:10.3390/microorganisms10020442 · Cited by 38
Epigenetic Regulation of Antifungal Drug Resistance
Patra, S., Raney, M., Pareek, A., & Kaur, R. (2022) · Journal of Fungi · doi:10.3390/jof8080875 · Cited by 38
The Microevolution of Antifungal Drug Resistance in Pathogenic Fungi
Boyce, K. J. (2023) · Microorganisms · doi:10.3390/microorganisms11112757 · Cited by 29
MSH2 Gene Point Mutations Are Not Antifungal Resistance Markers in Candida glabrata
Bordallo-Cardona, M. Á., Agnelli, C., Gómez-Nuñez, A., Sánchez-Carrillo, C., Bouza, E., Muñoz, P., Escribano, P., & Guinea, J. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01876-18 · Cited by 27
Lotfali, E., Fattahi, A., Sayyahfar, S., Ghasemi, R., Rabiei, M. M., Fathi, M., Vakili, K. G., Deravi, N., Soheili, A., Toreyhi, H., et al. (2021) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0235 · Cited by 23
Ara, B., Urmi, U. L., Haque, T. A., Nahar, S., Rumnaz, A., Ali, T., Alam, M. S., Mosaddek, A. S. M., Rahman, N. A. A., Haque, M., et al. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1901577 · Cited by 22
Moirangthem, R., Kumar, K., & Kaur, R. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02415-20 · Cited by 20
Shor, E., Schuyler, J., & Perlin, D. S. (2019) · mBio · doi:10.1128/mbio.00120-19 · Cited by 19
Self-citationGambhir, N., Harris, S. D., & Everhart, S. E. (2022) · mSphere · doi:10.1128/msphere.00087-22 · Cited by 19
Shankar, C., Pragasam, A. K., Anandan, S., & Veeraraghavan, B. (2019) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0415 · Cited by 19
The Mutator Phenotype: Adapting Microbial Evolution to Cancer Biology
Natali, F., & Rancati, G. I. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00713 · Cited by 19
Arastehfar, A. A., Daneshnia, F., Salehi, M., Zarrinfar, H., Khodavaisy, S., Haas, P., Roudbary, M., Najafzadeh, M. J., Zomorodian, K., Charsizadeh, A., et al. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000963 · Cited by 17
Naskar, S., Prajapati, A., & Kaur, R. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf025 · Cited by 17
Boyce, K. J., Cao, C., Xue, C., & Idnurm, A. (2020) · DNA Repair · doi:10.1016/j.dnarep.2019.102751 · Cited by 14
“These studies identified non-synonymous mutations in MSH2 but lacked an assessment of accurate mutation rate using fluctuation analysis [45-48].”
BackgroundResultAlbehaijani, S. H. I., Macreadie, I. G., Morrissey, C. O., & Boyce, K. J. (2022) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlac033 · Cited by 14
Lucio, J. L., González-Jiménez, I., Roldán, A., Amich, J., Alcázar‐Fuoli, L., & Mellado, E. (2024) · Journal of Fungi · doi:10.3390/jof10030210 · Cited by 13
Molecular epidemiology and antimicrobial resistance of vaginal Candida glabrata isolates in Namibia
Dunaiski, C. M., Kock, M. M., Chan, W. Y., Ismail, A., & Peters, R. P. H. (2024) · Medical Mycology · doi:10.1093/mmy/myae009 · Cited by 12
Insights into the global emergence of antifungal drug resistance
Boyce, K. J., Morrissey, O., Idnurm, A., & Macreadie, I. G. (2019) · Microbiology Australia · doi:10.1071/ma19024 · Cited by 10
Fattouh, N., Husni, R., Finianos, M., Bitar, I., & Khalaf, R. A. (2024) · Mycoses · doi:10.1111/myc.13750 · Cited by 5
Lighting Up Mutation: a New Unbiased System for the Measurement of Microbial Mutation Rates
Boyce, K. J., & Idnurm, A. (2019) · mBio · doi:10.1128/mbio.00740-19 · Cited by 5
Drug Resistance and Evolvability in an Emerging Human Fungal Pathogen
Billmyre, R. B. (2022) · mBio · doi:10.1128/mbio.01876-22 · Cited by 5
Fungicide Resistance: Surveillance, Risk Assessment and Evolution in Two Soil-Borne Pathogens
Gambhir, N. (2020) · Lincoln (University of Nebraska) · Cited by 4
Analysis of fks1 and fks2 gene mutations in invasive Candida glabrata strains from Pakistan
Memon, S., Ghanchi, N. K., Zafar, U., Farooqi, J. Q., Zaka, S., & Jabeen, K. (2022) · Mycoses · doi:10.1111/myc.13527 · Cited by 4
Zhang, G., Chen, Y., Chen, J., & Yao, D. (2024) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-024-00758-4 · Cited by 3
Zhang, H., Wei, W., Huang, M., Umar, Z., & Feng, Y. (2020) · Advanced Science · doi:10.1002/advs.202002530 · Cited by 3
Arastehfar, A. A., Daneshnia, F., Salehi, M., Zarrinfar, H., Khodavaisy, S., Haas, P., Roudbary, M., Najafzadeh, M. J., Zomorodian, K., Charsizadeh, A., et al. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001075 · Cited by 2
Pawar, K., & Singh, A. K. (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002083 · Cited by 1
Self-citationSkiba‐Kurek, I., Namysł, M., Kania, K., Czekajewska, J., Sepioło, A., Gosiewski, T., & Olechowska‐Jarząb, A. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18020213 · Cited by 1
Nimmala, P. A. P., Prakasham, S., & Anand, M. (2023) · Journal of Bacteriology and Mycology · doi:10.26420/jbacteriolmycol.2023.1205 · Cited by 1
Estudio de la resistencia a los antifúngicos en hongos patógenos humanos
Rivero-Menéndez, O. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
A Stress Response that Allows Highly Mutated Eukaryotic Cells to Survive and ProliferatePreprint
Zabinsky, R. A., Mares, J., She, R., Zeman, M. K., Chang, A., Talbot, J., Campbell, E., Monzavi, T., Silvers, T. R., & Jarosz, D. F. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4136719 · Cited by 1
Molecular epidemiology and treatment outcomes of vulvovaginal candidiasis in Namibian women
(2023) · UpSpace Institutional Repository (University of Pretoria) · doi:10.25403/upresearchdata.25208987 · Cited by 1
Heitman, J., Priest, S. J., & Yadav, V. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737092157.793576405
(2019) · Microbiology Australia · doi:10.1071/mav40n2
Ghazanfari, S., Mohammadi, S. R., Rezaie, S., Khodavaisy, S., & Samadani, A. A. (2022) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2022-0004
Megri, Y., Arastehfar, A. A., Boekhout, T., Daneshnia, F., Hörtnagl, C., Sartori, B., Hafez, A., Pan, W., Lass‐Flörl, C., & Hamrioui, B. (2020) · Figshare · doi:10.6084/m9.figshare.12096960
Belgacem, S., Chebil, W., Ferjani, I., Ghedira, D., Mastouri, M., & Babba, H. (2026) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2026.101601
Singh, A. (2026) · Radboud Repository (Radboud University)
Self-citation
Metadata
- Authors
- Singh, A., Healey, K. R., Yadav, P., Upadhyaya, G., Sachdeva, N., Sarma, S., Kumar, A., Tarai, B., Perlin, D. S., & Chowdhary, A.
- Affiliations
- University of Delhi (IN)
- Rutgers Health (US)
- Rajiv Gandhi Cancer Institute and Research Centre (IN)
- Medanta The Medicity (IN)
- Amrita Institute of Medical Sciences and Research Centre (IN)
- Max Healthcare (IN)
- ORCID
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2018-06
- Volume
- 62
- Issue
- 6
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC5971596
- OpenAlex
- W2794674824
- Cited by
- 56
- References
- 30
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 2 · 2022: 9 · 2021: 6 · 2020: 12 · 2019: 13 · 2018: 6
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Council of Scientific and Industrial Research, India (F. No. 09/174(0068)/2014-EMR-I)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Candida glabrata, antifungal resistance, azole resistance, echinocandin resistance, DNA mismatch repair, MSH2 mutation, mutator phenotype, caspofungin resistance, anidulafungin, micafungin, antifungal susceptibility, India
- MeSH terms
- Caspofungin, Micafungin, Anidulafungin, Antifungal Agents, Azoles, Candidiasis, Humans, India, Microbial Sensitivity Tests, Mutation, Drug Resistance, Fungal, Candida glabrata, DNA Mismatch Repair, Echinocandins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.